Oppenheimer & Co’s Kindred Healthcare KND Stock Holding History

Oppenheimer & Co’s Portfolio KND Stock Details KND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-17,500	Closed	-$158K	–	1427
2018 Q2	$158K	Hold	17,500	–	–	﹤0.01%	1252
2018 Q1	$160K	Hold	17,500	–	–	﹤0.01%	1251
2017 Q4	$170K	Buy	17,500 +3,000	+21%	+$22.3K	﹤0.01%	1234
2017 Q3	$99K	Buy	14,500 +4,500	+45%	+$38.3K	﹤0.01%	1250
2017 Q2	$117K	Sell	10,000 -3,000	-23%	-$29.6K	﹤0.01%	1251
2017 Q1	$109K	Sell	13,000 -4,000	-24%	-$31.3K	﹤0.01%	1241
2016 Q4	$134K	Sell	17,000 -16,000	-48%	-$131K	﹤0.01%	1209
2016 Q3	$337K	Buy	33,000 +2,000	+6%	+$22.2K	0.01%	946
2016 Q2	$350K	Buy	31,000 +1,000	+3%	+$12.5K	0.01%	918
2016 Q1	$370K	Buy	30,000 +2,000	+7%	+$20.7K	0.01%	862
2015 Q4	$334K	Sell	28,000 -4,500	-14%	-$58.2K	0.01%	912
2015 Q3	$512K	Hold	32,500	–	–	0.02%	796
2015 Q2	$659K	Sell	32,500 -7,200	-18%	-$165K	0.02%	767
2015 Q1	$945K	Buy	+39,700	New	+$805K	0.03%	649

Oppenheimer & Co's KND Position: Q3 2018 in Review

Oppenheimer & Co sold out of Kindred Healthcare (KND) in Q3 2018, closing a stake of 17,500 shares — an estimated $158K sold.

Oppenheimer & Co first reported a position in KND in Q1 2015 and held it in 14 quarters. The position peaked at $945K in Q1 2015. 0 funds tracked by Wall St. Rank hold KND as of Q3 2018.

Oppenheimer & Co reported no remaining Kindred Healthcare position as of Q3 2018 after selling out during the quarter.
Oppenheimer & Co sold 17,500 Kindred Healthcare shares in Q3 2018, an estimated $158K.
Oppenheimer & Co first reported a position in Kindred Healthcare in Q1 2015 and held it in 14 quarters.
Oppenheimer & Co's Kindred Healthcare position peaked at $945K in Q1 2015.
0 funds tracked by Wall St. Rank held Kindred Healthcare as of Q3 2018.

Based on Oppenheimer & Co's 13F filing for Q3 2018, filed 26 Oct 2018.